Borrego J, Mazuecos A, Gentil M A, Cabello M, Rodríguez A, Osuna A, Pérez M A, Castro P, Alonso M
Servicios de Nefrología at the Complejo Hospitalario de Jaén, Jaén, Spain.
Transplant Proc. 2013;45(10):3627-9. doi: 10.1016/j.transproceed.2013.10.025.
Certain factors can change the course of renal transplantation, such as acute rejection, ischemia time, and compatibility. Other donor and recipient factors may modify this evolution. Proteinuria modifies glomerular disease progression and may influence renal graft survival. In this study we analyzed proteinuria in patients who received a transplant since 2000 in Andalusia.
We studied the Andalusian Renal Transplant Registry from January 2000 to March 2012, recording data on 1815 patients who had proteinuria, registered at the third month and first year after transplantation. Three groups were formed, including those with proteinuria < 300 mg/24 h, those between 300 and 1000 mg/24 h, and those >1000 mg/24 h.
At the third month and the first year after transplantation, 65.7% and 71.6% of patients had proteinuria < 300 mg/24 h, 29.6% and 24.1% had proteinuria between 300 and 1000 mg/24 h, and 4.7% and 4.4% had proteinuria > 1,000 mg/24 h, respectively. We found differences between the three proteinuria groups in panel reactive antibodies (% PRA), serum creatinine at the third month and the first year, the etiology of the donor death, incidence of delayed renal function, and incidence of hypertension. The degree of proteinuria influenced graft and patient survival. In multivariate analysis, proteinuria was an independent risk factor for renal graft loss
The degree of proteinuria at the third month and the first year after transplantation is predictive of graft and patient survival. The patients who had more proteinuria at the third and 12th month after transplantation had worse renal function and more hypertension. Proteinuria is an independent risk factor for renal graft loss.
某些因素可改变肾移植的进程,如急性排斥反应、缺血时间和相容性。其他供体和受体因素可能会改变这种进展。蛋白尿会改变肾小球疾病的进程,并可能影响肾移植的存活。在本研究中,我们分析了自2000年以来在安达卢西亚接受移植的患者的蛋白尿情况。
我们研究了2000年1月至2012年3月的安达卢西亚肾移植登记处,记录了1815例有蛋白尿患者的数据,这些患者在移植后第三个月和第一年进行了登记。分为三组,包括蛋白尿<300mg/24h的患者、蛋白尿在300至1000mg/24h之间的患者以及蛋白尿>1000mg/24h的患者。
移植后第三个月和第一年,分别有65.7%和71.6%的患者蛋白尿<300mg/24h,29.6%和24.1%的患者蛋白尿在300至1000mg/24h之间,4.7%和4.4%的患者蛋白尿>1000mg/24h。我们发现三组蛋白尿患者在群体反应性抗体(%PRA)、第三个月和第一年的血清肌酐、供体死亡原因、肾功能延迟发生率和高血压发生率方面存在差异。蛋白尿程度影响移植肾和患者的存活。在多变量分析中,蛋白尿是肾移植丢失的独立危险因素。
移植后第三个月和第一年的蛋白尿程度可预测移植肾和患者的存活。移植后第三个月和第十二个月蛋白尿较多的患者肾功能较差且高血压较多。蛋白尿是肾移植丢失的独立危险因素。